Investigation of the impact of iron deficiency anemia on the clinical outcome of hospitalized patients and the 6-month outcome of acute STEMI patients undergoing primary angioplasty
Open Access
- 1 October 2024
- journal article
- Published by Maad Rayan Publishing Company in Biomedicine Advances
- Vol. 1 (1) , 20-26
Abstract
Background: Acute myocardial infarction (MI), particularly ST-elevation myocardial infarction (STEMI), is a severe form of acute coronary syndrome often resulting from complete coronary artery occlusion. Iron deficiency (ID) is a prevalent nutritional disorder worldwide and may influence cardiovascular outcomes, including in STEMI patients. This study aimed to assess the impact of ID on left ventricular function and clinical outcomes in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Methods: This prospective study included 257 patients with acute STEMI admitted to Shahid Madani hospital in Tabriz between October 2020 and October 2022. Patients who presented within 12 hours of chest pain onset and met the inclusion criteria were categorized into two groups based on the presence or absence of ID, defined by serum ferritin levels <100 mg/dL or transferrin saturation<20%. Comprehensive demographic, clinical, and angiographic data were collected. The primary outcomes assessed were the occurrence of major adverse cardiovascular events (MACE), thrombolysis in myocardial infarction (TIMI) flow grading, and enzymatic infarct size during hospitalization and at 6-month follow-up. Findings: ID was present in 54.4% of the patients. No significant differences were observed between the ID and non-ID groups regarding age, gender, body mass index (BMI), prevalence of comorbidities, or baseline left ventricular ejection fraction (LVEF). Additionally, the incidence of in-hospital and 6-month MACE, TIMI flow after PPCI, and enzymatic infarct size did not differ significantly between the two groups. However, serum iron, transferrin saturation, and ferritin levels were significantly lower in the ID group. Conclusion: Although ID was common among STEMI patients undergoing PPCI, it did not significantly affect in-hospital or 6-month outcomes. These findings suggest that ID may not be a crucial determinant of prognosis in STEMI patients, but further large-scale studies are needed to corroborate these results.Keywords
This publication has 27 references indexed in Scilit:
- Iron deficiency and all-cause mortality after myocardial infarctionEuropean Journal of Internal Medicine, 2024
- Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionInternational Journal of Cardiology, 2020
- Iron Deficiency Is a Determinant of Functional Capacity and Health-related Quality of Life 30 Days After an Acute Coronary SyndromeRevista Española de Cardiología (English Edition), 2017
- Heart FailureJACC, 2011
- Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial InfarctionThe American Journal of Cardiology, 2010
- Iron induces protection and necrosis in cultured cardiomyocytes: Role of reactive oxygen species and nitric oxideFree Radical Biology and Medicine, 2010
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)JACC, 2009
- Mitochondria and ischemia–reperfusion injury of the heart: Fixing a holeCardiovascular Research, 2006
- Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionJACC, 2004
- Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution widthArchives of internal medicine (1960), 1988